Radioactive copper ((64)Cu)-enabled theranostic delivery modulates cuproptosis-associated signaling for cancer treatment.

Song W, Tan R, Feng Y, Li X, Lee SJ, Engle JW, Cai W, Lan X, Zhang X

DOI: 10.1186/s12951-026-04901-5
Published: 2026 Aug 12
Container: Journal of nanobiotechnology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12951-026-04901-5,
  title = {Radioactive copper ((64)Cu)-enabled theranostic delivery modulates cuproptosis-associated signaling for cancer treatment.},
  author = {Song W and Tan R and Feng Y and Li X and Lee SJ and Engle JW and Cai W and Lan X and Zhang X},
  year = {2026},
  journal = {Journal of nanobiotechnology},
  doi = {10.1186/s12951-026-04901-5},
  url = {https://doi.org/10.1186/s12951-026-04901-5}
}

RIS

TY  - JOUR
TI  - Radioactive copper ((64)Cu)-enabled theranostic delivery modulates cuproptosis-associated signaling for cancer treatment.
AU  - Song W
AU  - Tan R
AU  - Feng Y
AU  - Li X
AU  - Lee SJ
AU  - Engle JW
AU  - Cai W
AU  - Lan X
AU  - Zhang X
PY  - 2026
JO  - Journal of nanobiotechnology
DO  - 10.1186/s12951-026-04901-5
UR  - https://doi.org/10.1186/s12951-026-04901-5
ER  -

APA

W, S., R, T., Y, F., X, L., SJ, L., JW, E., W, C., X, L., & X, Z. (2026). Radioactive copper ((64)Cu)-enabled theranostic delivery modulates cuproptosis-associated signaling for cancer treatment.. Journal of nanobiotechnology. https://doi.org/10.1186/s12951-026-04901-5

Source records

pubmed · retrieved 2026-11-10T13:42:40.209Z